Developing a Generic, Individualised Adherence Programme for Chronic Medication Users

Overview

Journal Pharm Pract (Granada)

Date 2014 Sep 2

PMID 25177406

Citations 16

Authors

Hanne Herborg

Lotte S Haugbolle

Lene Sorensen

Charlotte Rossing

Pernille Dam

Affiliations

Soon will be listed here.

Abstract

Objective: The scope of this article is to describe the background for and content of an adherence counselling programme with a specific focus on an individualised, multi-dimensional adherence model for patients with a potential adherence problem (a so-called 'individualised systems model').

Methods: An intervention programme based on WHO's systems model for adherence was developed for implementation in primary health care and tested in a development project in Danish pharmacies in 2004-2005 in three pharmacies and 4 GP practices by 27 patients. Data were collected from the participants by registration forms, questionnaires, and focus groups. Since the programme was to support patients in the self-management process regarding choice and implementation of medication treatment, various strategies were used and different theoretical assumptions and choices made prior to setting up the study. These strategies include distinguishing between different types of non-adherence, a model for stages of change, self-efficacy, narratives, motivating interviewing strategies and coaching techniques. These strategic and theoretical choices are described in the article.

Results: The strategies and theoretical reflections formed the platform for the creation of a counselling programme, which was tested in two forms, a basic and an extended version - provided by either a pharmaconomist or a pharmacist. The result section also describes a toolbox of instruments to enable pharmacy staff and GPs to tailor a counselling programme for patients individually called 'Safe and effective use of medicines'. Besides, the results include a description of how the WHO-model is transformed into an individualised counselling model.

Citing Articles

Changes in community pharmacy communication - Towards emotional awareness at the pharmacy counter.

Mottelson N, Husted G, Kaae S, Rossing C, Fosgerau C PEC Innov. 2025; 6:100380.

PMID: 40028462 PMC: 11871463. DOI: 10.1016/j.pecinn.2025.100380.

Prognostic factors of adherence to home-based exercise therapy in patients with chronic diseases: A systematic review and meta-analysis.

Ricke E, Dijkstra A, Bakker E Front Sports Act Living. 2023; 5:1035023.

PMID: 37033885 PMC: 10080001. DOI: 10.3389/fspor.2023.1035023.

Developing a pharmacist-led intervention to provide transitional pharmaceutical care for hospital discharged patients: A collaboration between hospital and community pharmacists.

Lech L, Rossing C, Andersen T, Norgaard L, Almarsdottir A Explor Res Clin Soc Pharm. 2022; 7:100177.

PMID: 36131887 PMC: 9483769. DOI: 10.1016/j.rcsop.2022.100177.

Involving patients in medicines optimisation in general practice: a development study of the "PREparing Patients for Active Involvement in medication Review" (PREPAIR) tool.

Sandbaek A, Moller M, Bro F, Hoj K, Christensen L, Mygind A BMC Prim Care. 2022; 23(1):122.

PMID: 35596147 PMC: 9121082. DOI: 10.1186/s12875-022-01733-8.

An Adaptable Framework for Factors Contributing to Medication Adherence: Results from a Systematic Review of 102 Conceptual Frameworks.

Peh K, Kwan Y, Goh H, Ramchandani H, Phang J, Lim Z J Gen Intern Med. 2021; 36(9):2784-2795.

PMID: 33660211 PMC: 8390603. DOI: 10.1007/s11606-021-06648-1.

References

Vergouwen A, Bakker A, Katon W, Verheij T, Koerselman F . Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 2004; 64(12):1415-20. DOI: 10.4088/jcp.v64n1203. View

Marinker M, Shaw J . Not to be taken as directed. BMJ. 2003; 326(7385):348-9. PMC: 1125224. DOI: 10.1136/bmj.326.7385.348. View

Benson J, Britten N . Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002; 325(7369):873. PMC: 129637. DOI: 10.1136/bmj.325.7369.873. View

Schroeder K, Fahey T, Ebrahim S . How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004; 164(7):722-32. DOI: 10.1001/archinte.164.7.722. View

Weingarten S, Henning J, Badamgarav E, Knight K, Hasselblad V, Gano Jr A . Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ. 2002; 325(7370):925. PMC: 130055. DOI: 10.1136/bmj.325.7370.925. View

Haynes R, Yao X, Degani A, Kripalani S, Garg A, McDONALD H . Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005; (4):CD000011. DOI: 10.1002/14651858.CD000011.pub2. View

Stason W . Compliance, quality of life, and cost effectiveness. Curr Hypertens Rep. 2000; 1(6):471-4. DOI: 10.1007/s11906-996-0017-8. View

Charon R . The patient-physician relationship. Narrative medicine: a model for empathy, reflection, profession, and trust. JAMA. 2001; 286(15):1897-902. DOI: 10.1001/jama.286.15.1897. View

Prochaska J, DiClemente C, Norcross J . In search of how people change. Applications to addictive behaviors. Am Psychol. 1992; 47(9):1102-14. DOI: 10.1037//0003-066x.47.9.1102. View

10.

Haynes R, McKibbon K, Kanani R . Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996; 348(9024):383-6. DOI: 10.1016/s0140-6736(96)01073-2. View

11.

Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler C . Improving drug therapy for patients with asthma--part 1: Patient outcomes. J Am Pharm Assoc (Wash). 2001; 41(4):539-50. DOI: 10.1016/s1086-5802(16)31278-5. View

12.

Park J, Kelly P, Carter B, Burgess P . Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash). 1996; NS36(7):443-51. DOI: 10.1016/s1086-5802(16)30099-7. View

13.

DiMatteo M . Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004; 42(3):200-9. DOI: 10.1097/01.mlr.0000114908.90348.f9. View

14.

Rand C . Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol. 1993; 72(10):68D-74D. DOI: 10.1016/0002-9149(93)90014-4. View

15.

Bandura A . Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977; 84(2):191-215. DOI: 10.1037//0033-295x.84.2.191. View

16.

Hepler C . Pharmaceutical care versus traditional drug treatment. Is there a difference?. Drugs. 1995; 49(1):1-10. DOI: 10.2165/00003495-199549010-00001. View

17.

Burnier M, Schneider M, Chiolero A, Stubi C, Brunner H . Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens. 2001; 19(2):335-41. DOI: 10.1097/00004872-200102000-00022. View

18.

Barber N . Should we consider non-compliance a medical error?. Qual Saf Health Care. 2002; 11(1):81-4. PMC: 1743570. DOI: 10.1136/qhc.11.1.81. View

19.

Carter B, Barnette D, Chrischilles E, Mazzotti G, Asali Z . Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997; 17(6):1274-85. View

20.

Munroe W, Kunz K, Potter L, Schonfeld W . Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther. 1997; 19(1):113-23. DOI: 10.1016/s0149-2918(97)80078-1. View